FindTrial
Sign In

Lymph node metastases detected at post-ablation 131I scintigraphy as a prognostic factor of papillary thyroid cancer

Lymph node metastases detected at post-ablation 131I scintigraphy as a prognostic factor of papillary thyroid cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048092
Enrollment
Unknown
Registered
2021-06-30
Start date
2012-01-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Differentiated thyroid cancer

Interventions

Case series:Nil

Sponsors

The First Affiliated Hospital, Medical School of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years old, diagnosed intermediate-risk DTC patients with naive iodine treatment; 2. Total thyroidectomy has been performed; 3. No history of neck irradiation, no history of other tumors, no acute inflammatory diseases; 4. Completely evaluate the clinical data before and after treatment.

Exclusion criteria

Exclusion criteria: 1. Serious illness, difficult to cooperate / unable to follow up the survival period; 2. Loss of follow-up.

Design outcomes

Primary

MeasureTime frame
Relapse Free Survival (RFS);Iodine imaging results;—

Secondary

MeasureTime frame
Serum triglycerides (TG);Serum anti-thyroglobulin antibodies(TgAb);—

Countries

China

Contacts

Public ContactGao Rui

The First Affiliated Hospital, Medical School of Xi'an Jiaotong University

mydjx@126.com+86 13772488039

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026